Vulnerability in Capsuletech Smartlinx Neuron 2

CVE-2019-5024

A restricted environment escape vulnerability exists in the “kiosk mode” function of Capsule Technologies SmartLinx Neuron 2 medical information collection devices running versions 9.0.3 or lower. A specific series of keyboard inputs can escape the restricted environment, resulting in full administrator access to the underlying operating system. An attacker can connect to the device via USB port with a keyboard or other HID device to trigger this vulnerability.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.6 (High). Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.005 (38.5th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 39th percentile — 38.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2019-5024: held from 0.005 to 0.005.

EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2019-5024?
CVE-2019-5024 is a high-severity vulnerability in Capsuletech Smartlinx Neuron 2, classified under Protection Mechanism Failure. CVSS score: 7.6/10. Published 2019-04-11.
How severe is CVE-2019-5024?
High severity. CVSS v3 base score is 7.6 out of 10.